Comunicados de prensa
Abril 22, 2020
Novartis maintains strong operational performance in Q1, confirms FY 2020 guidance at this time, and advances a broad range of efforts to support the global response to COVID-19
Abril 20, 2020
Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo
Marzo 25, 2020
Sandoz announces new country head for Japan